Sign in
EI

Ecovyst Inc. (ECVT)·Q4 2019 Earnings Summary

Executive Summary

  • Q4 2019 sales fell 7.3% to $352.4M, with Adjusted EBITDA of $103.1M and Adjusted diluted EPS of $0.13; catalysts outperformed while refining and performance chemicals were hampered by unplanned outages and silicate destocking .
  • Full-year Adjusted EBITDA rose to $474.3M with a 100 bps margin expansion; record Adjusted FCF of $166.2M enabled $215M of debt repayment and leverage reduction to 3.9x, creating balance sheet flexibility .
  • 2020 guide: sales $1.595–$1.625B, Adjusted EBITDA $470–$480M, Adjusted diluted EPS $0.85–$1.02, and Adjusted FCF $155–$175M; Q1 EBITDA expected below 1Q19; catalysts to step down after an exceptional 2019 while chemicals improve in 2H on restocking and transformation benefits .
  • Strategic actions: launched a Performance Chemicals transformation (manufacturing, network, commercial discipline, IBP) targeting a $10–$15M run-rate EBITDA uplift; executed ThermoDrop-for-glass-beads asset swap paired with a 10-year supply contract to reinforce highway safety positioning—both supportive to mix/returns going forward .

What Went Well and What Went Wrong

  • What Went Well

    • Catalysts delivered a strong Q4: Adjusted EBITDA +50.8% YoY to $28.5M; margins expanded >800 bps to 40% on robust hydrocracking and MMA demand and favorable mix .
    • Performance Materials improved profitability despite lower sales: Adjusted EBITDA +6.7% YoY to $11.2M; margin +230 bps to 16.5% on pricing and lower freight/operating costs .
    • “We had a better-than-expected finish to the year, driven by our outstanding results from our catalysts business in the fourth quarter” — CFO Michael Crews . Record Adjusted FCF ($166.2M) and leverage cut to 3.9x strengthened financial flexibility .
  • What Went Wrong

    • Refining Services impacted by outages and lower sulfur pass-through: sales -11.5% to $105.7M, Adjusted EBITDA -16.4% to $41.9M; prior year included a $4M insurance gain .
    • Performance Chemicals softness persisted: sales -5.9% to $158.9M; Adjusted EBITDA -14.3% to $33.6M, reflecting weaker sodium silicate demand in the Americas .
    • Unplanned customer outages extended into early 2020; sulfur prices at decade lows limit top-line but not EBITDA for refining; Q1 EBITDA guided below 1Q19 .

Financial Results

Consolidated performance vs prior periods (oldest → newest)

MetricQ4 2018Q2 2019Q3 2019Q4 2019
Revenue ($M)$380.1 $431.7 $423.8 $352.4
Diluted EPS ($)$0.21 $0.23 $0.20 $0.14
Adjusted Diluted EPS ($)$0.17 $0.31 $0.36 $0.13
Adjusted EBITDA ($M)$109.1 $132.5 $137.7 $103.1
Adjusted EBITDA Margin (%)26.2% 28.1% 28.8% 25.8%

Segment breakdown (Q4 YoY)

SegmentSales Q4 2018 ($M)Sales Q4 2019 ($M)YoY %Adj. EBITDA Q4 2018 ($M)Adj. EBITDA Q4 2019 ($M)YoY %Q4’19 Margin
Refining Services119.4 105.7 -11.5% 50.1 41.9 -16.4% 39.6%
Catalysts (Adj. EBITDA)18.9 28.5 +50.8% 40.4%
• Silica Catalysts sales22.0 23.3 +5.9%
• Zeolyst JV sales36.5 47.3 +29.6%
Performance Materials73.7 67.9 -7.9% 10.5 11.2 +6.7% 16.5%
Performance Chemicals168.8 158.9 -5.9% 39.2 33.6 -14.3% 21.1%

Select KPIs and cash/leveraging

KPIQ3 2019Q4 2019
Adjusted Free Cash Flow ($M)$99.6 $67.6
Net Cash from Operating Activities (quarter, $M)$121.9 $85.8
Net Debt / Adjusted EBITDA (x)4.1x (9/30/19) 3.9x (12/31/19)
Debt Repayments YTD ($M)$100 (through Aug) $215 (FY 2019)

Estimates vs. Actuals (consensus unavailable)

  • Wall Street consensus (S&P Global) for Q4 2019 EPS/Revenue/EBITDA was unavailable due to access limits at the time of analysis; we will update on request. As a result, no beat/miss designation is provided. (Consensus via S&P Global—temporarily unavailable.)

Guidance Changes

MetricPeriodPrevious GuidanceCurrent GuidanceChange
SalesFY 2020N/A$1.595B–$1.625B New
Adjusted EBITDAFY 2020N/A$470M–$480M New
Adjusted Diluted EPSFY 2020N/A$0.85–$1.02 New
Adjusted Free Cash FlowFY 2020N/A$155M–$175M New
EBITDA (Q1 outlook)Q1 2020N/ABelow 1Q19 (low single-digit decline) New
Catalysts segmentFY 2020N/AEBITDA down low double digits vs. 2019; margins ~2018 levels New
Refining ServicesFY 2020N/AFlat to low-single-digit sales (sulfur pass-through), mid-single-digit EBITDA growth New
Performance MaterialsFY 2020N/AMid-single-digit sales and EBITDA growth; similar margins to 2019 New
Performance ChemicalsFY 2020N/AFlat to low-single-digit sales; mid-single-digit EBITDA growth with ~half from transformation New

Earnings Call Themes & Trends

TopicPrevious Mentions (Q2 & Q3 2019)Current Period (Q4 2019)Trend
Hydrocracking catalysts demand (Zeolyst JV)Q2: H2 strength expected with Q3 strongest for HC catalysts; strong polyolefin; order timing noted . Q3: HC catalysts strongest quarter; mix tailwinds; double-digit catalysts EBITDA growth .2019 was “very exceptional” for hydrocracking; 2020 expected down vs. 2019 but above 2018; lumpiness persists .Normalizing after peak 2019
Silica catalysts/polyolefinQ2/Q3: Double-digit growth on PE capacity additions (U.S./China) and INEOS agreement broadens portfolio .Continued double-digit growth expected in 2020; strength in HDPE catalysts; not exposed to single-use LDPE pressure .Positive/expanding
Performance Chemicals (sodium silicate)Q2: Weaker demand (Europe/Mexico); Q3: broad-based destocking; margin pressure from maintenance/logistics .Volumes down ~8% in Q4; destocking persists into 1H20; 2H restocking expected; transformation to drive ~$10–$15M run-rate EBITDA when complete .Weak near-term; recovery 2H20
Refining Services: outages/sulfurQ2/Q3: Unplanned customer outages weighed on volumes; higher pricing offset; pass-through of lower sulfur limits sales .Outages extended into Jan; sulfur at ~10-year lows constrains sales but no EBITDA impact; expect EBITDA growth for 2020 .Operating normalization expected
IMO 2020 / alkylation dynamicsQ3: Limited direct impact on refining; HC activity timing drives JV; alkylation demand strong .IMO transition smoother than expected; ongoing demand increase; potential future HC peaks (e.g., 2022) .Supportive
Portfolio optimization/INEOS allianceQ3: INEOS agreement to expand Ziegler–Natta offering; capital-light growth .Long-term ThermoDrop swap for U.S. glass beads assets + 10-year contract; focus on core highway safety .Executing capital-light moves

Management Commentary

  • “We had a better-than-expected finish to the year, driven by our outstanding results from our catalysts business in the fourth quarter… For the year, we posted growth in both adjusted EBITDA and margins.” — CFO Michael Crews .
  • “Strong commercial execution and improved capital efficiency coupled with asset monetizations drove a record $166 million of Adjusted free cash flow… [and] reduced our leverage ratio by more than one-half turn” — CEO Belgacem Chariag (press release) .
  • On Performance Chemicals transformation: “We… kicked off a transformation plan… manufacturing excellence, network optimization, commercial discipline and integrated business management… targeting a run rate improvement in adjusted EBITDA of $10 million to $15 million” .
  • On catalysts trajectory: “Hydrocracking activity was very strong in 2019… next year activity will be lower because this was… exceptional… but… we’re still higher than 2018” — CEO .
  • On ThermoDrop swap: “It will improve our network… and… improve the bottom line… we see growth in the mid-single-digit range [for Performance Materials]” — CEO and CFO .

Q&A Highlights

  • Capital allocation and leverage: Target leverage 3.0–3.5x; primary 2020 FCF use is debt reduction; once in range, bolt-ons or dividends considered .
  • Performance Chemicals transformation benefits: About half of 2020 segment EBITDA growth expected from transformation; cash costs incorporated in guidance .
  • ThermoDrop-for-glass-beads transaction: 10-year glass bead supply contract; swap improves network and margins over time; 2020 Performance Materials growth mid-single digits with similar margin profile to 2019 .
  • Refining outages/sulfur: Some outages extended into Q1; sales impacted by sulfur pass-through but EBITDA unaffected; mid-single-digit EBITDA growth expected for 2020 .
  • Cash flow bridge 2020: At EBITDA midpoint, ~$(100)M cash interest, ~$25M cash taxes, lower WC use, ~$10–$11M pension, and transformation cash outlays embedded in FCF guide .

Estimates Context

  • S&P Global consensus for Q4 2019 EPS/Revenue/EBITDA was not retrievable at the time of analysis due to access limits; therefore, we cannot provide beat/miss determinations. We will update with S&P Global consensus upon request.

Key Takeaways for Investors

  • Catalysts delivered a high-quality finish to 2019; 2020 will “reset” lower vs. an exceptional 2019 but remains above 2018, with polyolefin catalysts still growing double digits—supportive for mid-cycle profitability .
  • Performance Chemicals is the near-term swing factor: destocking weighs in 1H20, but restocking and a targeted $10–$15M run-rate EBITDA uplift from transformation should improve trajectory into 2H20 and 2021 .
  • Refining Services fundamentals intact: sulfur price pass-through caps sales optics, but EBITDA remains resilient; backlog of outages should normalize, enabling mid-single-digit EBITDA growth .
  • Balance sheet improved: record Adjusted FCF and $215M debt reduction lowered leverage to 3.9x; 2020 guide implies continued strong cash generation and scope for capital allocation optionality as leverage approaches target range .
  • Strategic portfolio moves are capital-light and mix-accretive: INEOS agreement broadens catalysts offerings, while ThermoDrop swap and 10-year beads contract sharpen highway safety positioning and potential margin expansion over time .
  • Near-term trading setup: Q1 EBITDA guided below prior year and catalysts down YoY in 2020 could temper momentum; watch for 2H20 improvement in chemicals and continued strength in polyolefin catalysts as catalysts for sentiment .